Author: Michelle Pancake
Above is the chemical structure of Cannabidiol or CBD , one of 113 active cannabinoids in cannabis (image credit wikimedia commons)
A groundbreaking article by CNN highlights a scientific study published in the New England Journal of Medicine showing that cannabidiol (CBD) is medically beneficial. The 14-day, double-blind, placebo-controlled human trial resulted in significantly reduced seizures in children with a severe epilepsy disorder called Dravet Syndrome. These children suffer from seizures at rates from 4 to 1,717 seizures per month, causing developmental delays, speech and lanugage problems, behavioral issues and movement problems. The study’s results show that those given CBD had 39% less seizures, compared to those given the placebo who had 13% less seizures. Nearly all did experience side effects, drowsyness most common, loss of appetite, vomiting and diarrhea. Amazingly, 5% of the 120 children became entirely seizure-free during the 14-week study.
This study is a necessary step to move marijuana off of the schedule 1 controlled substance list, which makes it difficult to do federally approved studies on its possible medicinal values. As schedule 1 it is currently considered to have virtually no medicinal value, and high potential for abuse. Many populations are already using marijuana to treat medical conditions, so this study could improve access by opening the door for more research studies, and possibly drop marijuana from schedule 1 to reflect it’s true medicinal value.
Read the CNN article HERE
Read the original study HERE